Mead Johnson Wins Federal Enfamil Trial
A US federal jury ruled in favor of Mead Johnson in a test trial over claims that its Enfamil infant formula caused a dangerous bowel disease in premature babies. The company welcomed the verdict, stating science does not support the lawsuits.
Xurve View
Insights:
Xurve View
Reckitt Benckiser Group Plc's Mead Johnson unit won a United States federal bellwether trial on Monday evening over claims that its Enfamil premature infant formula caused a dangerous bowel disease. The Illinois jury concluded the formula did not cause a preterm baby boy to develop necrotizing enterocolitis. The verdict provides legal relief as the company faces nearly 1,700 similar lawsuits.
